Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Camanni

Showing results (131-140 of 228) with videos related to

Pageof 23
Sort By:
Journal of Endocrinological Investigation|January 24, 1998
Reduction of the somatotrope responsiveness to GHRH and Hexarelin but not to arginine plus GHRH in hyperprolactinemic patientsS Grottoli, P Razzore, E Arvat, et al.
Neuroendocrinology|January 16, 1998
Hexarelin, a synthetic growth-hormone releasing peptide, shows no interaction with corticotropin-releasing hormone and vasopressin on adrenocorticotropin and cortisol secretion in humansE Arvat, B Maccagno, J Ramunni, et al.
European Journal of Endocrinology|September 1, 1995
Effect of galanin on basal and stimulated secretion of prolactin, gonadotropins, thyrotropin, adrenocorticotropin and cortisol in humansE Arvat, L Gianotti, J Ramunni, et al.
Journal of Endocrinological Investigation|July 1, 1980
Neurotransmitter control of growth hormone, thyrotropin and prolactin secretionE E Müller, A R Genazzani, D Cocchi, et al.
Journal of Endocrinological Investigation|June 20, 1998
Effects of 3-month nifedipine treatment on endocrine-metabolic parameters in patients with abdominal obesity and mild hypertensionM Maccario, S E Oleandri, E Avogadri, et al.
European Journal of Endocrinology|November 1, 1994
Growth hormone-releasing activity of growth hormone-releasing peptide-6 is maintained after short-term oral pretreatment with the hexapeptide in normal agingE Ghigo, E Arvat, G Rizzi, et al.
Journal of Endocrinological Investigation|March 1, 1997
Effects of histaminergic antagonists on the GH-releasing activity of GHRH or hexarelin, a synthetic hexapeptide, in manE Arvat, B Maccagno, J Ramunni, et al.
Clinical Endocrinology|December 24, 1997
Low hexarelin dose and pyridostigmine have additive effect and potentiate to the same extent the GHRH-induced GH response in manE Arvat, L Di Vito, J Ramunni, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1994
Arginine and growth hormone-releasing hormone restore the blunted growth hormone-releasing activity of hexarelin in elderly subjectsE Arvat, L Gianotti, S Grottoli, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1987
Enhancement of cholinergic tone by pyridostigmine promotes both basal and growth hormone (GH)-releasing hormone-induced GH secretion in children of short statureE Ghigo, E Mazza, E Imperiale, et al.
Pageof 23

Showing results (131-140 of 228) with videos related to

Sort By:
Pageof 23
Journal of Endocrinological Investigation|January 24, 1998
Reduction of the somatotrope responsiveness to GHRH and Hexarelin but not to arginine plus GHRH in hyperprolactinemic patientsS Grottoli, P Razzore, E Arvat, et al.
Neuroendocrinology|January 16, 1998
Hexarelin, a synthetic growth-hormone releasing peptide, shows no interaction with corticotropin-releasing hormone and vasopressin on adrenocorticotropin and cortisol secretion in humansE Arvat, B Maccagno, J Ramunni, et al.
European Journal of Endocrinology|September 1, 1995
Effect of galanin on basal and stimulated secretion of prolactin, gonadotropins, thyrotropin, adrenocorticotropin and cortisol in humansE Arvat, L Gianotti, J Ramunni, et al.
Journal of Endocrinological Investigation|July 1, 1980
Neurotransmitter control of growth hormone, thyrotropin and prolactin secretionE E Müller, A R Genazzani, D Cocchi, et al.
Journal of Endocrinological Investigation|June 20, 1998
Effects of 3-month nifedipine treatment on endocrine-metabolic parameters in patients with abdominal obesity and mild hypertensionM Maccario, S E Oleandri, E Avogadri, et al.
European Journal of Endocrinology|November 1, 1994
Growth hormone-releasing activity of growth hormone-releasing peptide-6 is maintained after short-term oral pretreatment with the hexapeptide in normal agingE Ghigo, E Arvat, G Rizzi, et al.
Journal of Endocrinological Investigation|March 1, 1997
Effects of histaminergic antagonists on the GH-releasing activity of GHRH or hexarelin, a synthetic hexapeptide, in manE Arvat, B Maccagno, J Ramunni, et al.
Clinical Endocrinology|December 24, 1997
Low hexarelin dose and pyridostigmine have additive effect and potentiate to the same extent the GHRH-induced GH response in manE Arvat, L Di Vito, J Ramunni, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1994
Arginine and growth hormone-releasing hormone restore the blunted growth hormone-releasing activity of hexarelin in elderly subjectsE Arvat, L Gianotti, S Grottoli, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1987
Enhancement of cholinergic tone by pyridostigmine promotes both basal and growth hormone (GH)-releasing hormone-induced GH secretion in children of short statureE Ghigo, E Mazza, E Imperiale, et al.
Pageof 23